No connection

Search Results

PDLB

BULLISH
$17.51 Live
Ponce Financial Group, Inc. · NASDAQ
$10.88 52W Range $18.01

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 17, 2026
Market cap
$400.77M
P/E
14.59
ROE
5.5%
Profit margin
27.2%
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
75%
PDLB presents a compelling value opportunity, trading at $17.51, which is below both its Graham Number ($19.29) and its growth-based intrinsic value ($35.4). While the Piotroski F-Score of 4/9 indicates only stable financial health, the company is experiencing explosive earnings growth (264.10% YoY) and consistent earnings beats. The primary disconnect lies between strong fundamental growth and bearish technicals/insider sentiment. Overall, the valuation gap and growth trajectory outweigh the mediocre health score.

Key Strengths

Trading below Graham Number ($19.29) and Intrinsic Value ($35.4)
Exceptional earnings growth of 264.10% YoY
Strong track record of earnings surprises (3/4 beats in last 4 quarters)
Low P/E ratio (14.59) relative to massive growth rates
High operating margin of 45.49%

Key Risks

Low Return on Equity (5.48%) and Return on Assets (0.92%)
Bearish insider sentiment with recent selling activity
Very weak technical trend (10/100)
Piotroski F-Score of 4/9 suggests only mediocre financial health
Lack of analyst coverage and target price guidance
AI Fair Value Estimate
Based on comprehensive analysis
$27.35
+56.2% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
56
Moderate
Value
85
Future
90
Past
60
Health
45
Dividend
0
AI Verdict
Undervalued Growth
Key drivers: Earnings Growth, Price-to-Graham Gap, Earnings Surprise Trend
Confidence
80%
Value
85/100

Ref P/E 14.59, Graham Number $19.29

Positives
  • Price < Graham Number
  • Low Forward P/E (12.33)
  • Price/Book of 1.27 is reasonable for the sector
Watchpoints
  • Price/Sales is slightly high at 3.80
Future
90/100

Ref Growth rates

Positives
  • Revenue growth 38.30% YoY
  • Earnings growth 264.10% YoY
  • Strong Q/Q earnings momentum
Watchpoints
  • Sustainability of triple-digit growth is uncertain
Past
60/100

Ref Historical trends

Positives
  • Strong recovery in EPS since 2023
  • Consistent beats in the last 2 years
Watchpoints
  • Significant volatility and misses in 2020-2022
Health
45/100

Ref Piotroski F-Score 4/9

Positives
  • Piotroski score is in the 'Stable' range
Watchpoints
  • Low ROE (5.48%)
  • Low ROA (0.92%)
  • Piotroski score 4/9 is not 'Strong'
Dividend
0/100

Ref Yield N/A

Positives
No standout positives identified.
Watchpoints
  • No dividend payments
  • 0% payout ratio

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$17.51

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for PDLB and closest competitors.

Updated 2026-04-16
PDL
Ponce Financial Group, Inc.
Primary
5Y
+118.5%
3Y
+124.2%
1Y
+57.6%
6M
+24.9%
1M
+6.4%
1W
-1.7%
GBL
Global Indemnity Group, LLC
Peer
5Y
+20.4%
3Y
+13.2%
1Y
-4.0%
6M
-2.2%
1M
-3.1%
1W
+1.6%
BWF
Bankwell Financial Group, Inc.
Peer
5Y
+112.0%
3Y
+132.2%
1Y
+83.3%
6M
+18.3%
1M
+9.1%
1W
+4.5%
GCB
Greene County Bancorp, Inc.
Peer
5Y
+98.4%
3Y
+10.1%
1Y
+8.4%
6M
+4.8%
1M
+4.7%
1W
+1.7%
GLA
Gladstone Capital Corporation
Peer
5Y
+25.5%
3Y
+25.6%
1Y
-23.1%
6M
-7.3%
1M
-2.7%
1W
-2.6%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
14.59
Forward P/E
12.33
PEG Ratio
N/A
P/B Ratio
1.27
P/S Ratio
3.8
EV/Revenue
10.88
EV/EBITDA
N/A
Market Cap
$400.77M

Profitability

Profit margins and return metrics

Profit Margin 27.22%
Operating Margin 45.48%
Gross Margin N/A
ROE 5.48%
ROA 0.92%

Growth

Revenue and earnings growth rates

Revenue Growth +38.3%
Earnings Growth +264.1%
Q/Q Revenue Growth +40.91%
Q/Q Earnings Growth +245.6%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$5.23

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Net Margin
32.4%
Total Assets
$3.2B
Liabilities
$2.7B
Equity
$0.5B
Debt/Equity
4.95x
Operating CF
$0.0B
Free Cash Flow
$0.0B
FCF Yield
100%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-04-24
$N/A
2026-01-27
$0.42
+50.0% surprise
2025-10-24
$0.27
+22.7% surprise
2025-07-25
$0.25
+47.1% surprise

Financial Services Sector Comparison

Comparing PDLB against 579 companies in the Financial Services sector (106 bullish, 239 neutral, 234 bearish)
P/E Ratio
14.59
This Stock
vs
41.68
Sector Avg
-65.0% (Discount)
Return on Equity (ROE)
5.48%
This Stock
vs
-0.24%
Sector Avg
-2356.8% (Below Avg)
Profit Margin
27.22%
This Stock
vs
47.47%
Sector Avg
-42.7% (Weaker)
Revenue Growth
38.3%
This Stock
vs
39.3%
Sector Avg
-2.5% (Slower)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

KOUZILOS IOANNIS
Officer
Sell
2026-02-11
10,929 shares · $183,716
KOUZILOS IOANNIS
Officer
Option Exercise
2026-02-11
10,929 shares · $125,519
CAMPIZ BETTY YOLAINY
Officer
Stock Award
2026-02-09
10,000 shares
DELEON MELISSA ANTONIA
Officer
Stock Award
2026-02-09
5,000 shares
NAUDON CARLOS P
Chief Executive Officer
Stock Award
2026-01-22
15,000 shares
KOUZILOS IOANNIS
Officer
Stock Award
2026-01-22
5,000 shares
TSAVARIS STEVEN A
Officer and Director
Stock Award
2026-01-22
15,000 shares
GONZALEZ LUIS GERARDO JR.
Chief Operating Officer
Stock Award
2026-01-22
5,000 shares
VACCARO SERGIO JAVIER
Chief Financial Officer
Stock Award
2026-01-22
10,000 shares
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-03-31
10-K
10-K
2026-03-13

PDLB filed its annual 10-K report on March 13, 2026. Due to the absence of detailed text in the provided excerpts, specific financial highlights and risk factors cannot be determined.

8-K
8-K
2026-01-27

ProKidney Corp. filed an 8-K on January 27, 2026, likely to announce its fourth quarter and full-year financial results.

10-Q
10-Q
2025-11-05

PDLB filed its quarterly 10-Q report on November 5, 2025. While the filing includes a dedicated section for Risk Factors, no specific financial highlights or detailed risk descriptions were provided in the available excerpts.

8-K
8-K
2025-10-24

PDLB filed an 8-K on October 24, 2025, likely to announce its third-quarter financial results.

8-K
8-K
2025-10-14
10-Q
10-Q
2025-08-06

PDLB filed its 10-Q on August 6, 2025. Due to the limited content provided in the excerpt, specific financial highlights and detailed risk factors are unavailable.

8-K
8-K
2025-07-25
8-K
8-K
2025-06-17
8-K
8-K
2025-05-13

PDLB filed an 8-K on May 13, 2025, likely to announce its first-quarter financial results.

10-Q
10-Q
2025-05-06
8-K
8-K
2025-04-25
DEF 14A
DEF 14A
2025-04-23
10-K
10-K
2025-03-13
8-K
8-K
2025-01-28
Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning PDLB from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile